IMMUNOPHENOTYPIC DESCRIPTION OF PATIENTS WITH A MYELODYSPLASTIC SYNDROME AND 2 SPECIFIC CYTOGENETICS ABNORMALITIES: DELETION OF 5Q AND TRISOMY 8

被引：0
|
作者：
Subira, M. [1 ]
Font, P. [2 ]
Arranz, E. [3 ]
Serrano, C. [1 ]
Gonzalo, R. [1 ]
Castanon, S. [1 ]
Mata, R. [1 ]
Soto, C. [1 ]
Olaso, E. [4 ]
Roman, A. [1 ]
Lamas, P. L. [1 ]
机构：
[1] Fdn Jimenez Diaz, E-28040 Madrid, Spain
[2] Clin Moncloa, Madrid, Spain
[3] Gemolab Lab, Madrid, Spain
[4] Clin Santa Elena, Madrid, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0719
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [1] Myelodysplastic syndromes (MDS) with a deletion 5q display a specific immunophenotypic profile
    Oelschlaegel, U.
    Westers, T. M.
    Mohr, B.
    Parmentier, S.
    Sockel, K.
    Bornhaeuser, M.
    Van de Loosdrecht, A. A.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2013, 37 : S47 - S48
  • [2] 5q deletion myelodysplastic syndrome
    Chari, Preethi S.
    Chander, Smitha
    Sundareshan, T. S.
    Prasad, Sujay
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (02) : 301 - +
  • [3] Chromosome 5q deletion in myelodysplastic syndrome
    Dwilewicz-Trojaczek, J.
    Madry, K.
    Paluszewska, M.
    Wiater, E.
    Szmigielska, A.
    Mital, A.
    Sledziowski, P.
    Salamanczuk, Z.
    Sikorska, A.
    Helbig, G.
    Wasilewska, E.
    Biedron, M.
    Calbecka, M.
    Jedrzejczak, W. W.
    LEUKEMIA RESEARCH, 2007, 31 : S91 - S91
  • [4] Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
    Mallo, M.
    Cervera, J.
    Schanz, J.
    Such, E.
    Garcia-Manero, G.
    Luno, E.
    Steidl, C.
    Espinet, B.
    Vallespi, T.
    Germing, U.
    Blum, S.
    Ohyashiki, K.
    Grau, J.
    Pfeilstoecker, M.
    Hernandez, J. M.
    Noesslinger, T.
    Giagounidis, A.
    Aul, C.
    Calasanz, M. J.
    Martin, M. L.
    Valent, P.
    Collado, R.
    Haferlach, C.
    Fonatsch, C.
    Luebbert, M.
    Stauder, R.
    Hildebrandt, B.
    Krieger, O.
    Pedro, C.
    Arenillas, L.
    Sanz, M. A.
    Valencia, A.
    Florensa, L.
    Sanz, G. F.
    Haase, D.
    Sole, F.
    LEUKEMIA, 2011, 25 (01) : 110 - 120
  • [5] Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
    M Mallo
    J Cervera
    J Schanz
    E Such
    G García-Manero
    E Luño
    C Steidl
    B Espinet
    T Vallespí
    U Germing
    S Blum
    K Ohyashiki
    J Grau
    M Pfeilstöcker
    J M Hernández
    T Noesslinger
    A Giagounidis
    C Aul
    M J Calasanz
    M L Martín
    P Valent
    R Collado
    C Haferlach
    C Fonatsch
    M Lübbert
    R Stauder
    B Hildebrandt
    O Krieger
    C Pedro
    L Arenillas
    M Á Sanz
    A Valencia
    L Florensa
    G F Sanz
    D Haase
    F Solé
    Leukemia, 2011, 25 : 110 - 120
  • [6] Impact of Number of Cells Harboring Deletion 5q Abnormality by Conventional Cytogenetics in Isolated Deletion 5q Myelodysplastic Syndromes
    Al Ali, Najla
    Sallman, David
    Padron, Eric
    Chan, Onyee
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S315 - S316
  • [7] Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion
    Giagounidis, AAN
    Haase, S
    Germing, U
    Heinsch, M
    Aul, C
    ACTA HAEMATOLOGICA, 2005, 113 (02) : 146 - 149
  • [8] Molecular Dissection of the 5q Deletion in Myelodysplastic Syndrome
    Ebert, Benjamin L.
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 621 - 626
  • [9] A NEW CRITICAL DELETION OF 5Q IN MYELODYSPLASTIC SYNDROME
    PHILLIPS, CN
    PRIEST, JH
    VOGLER, WR
    CLINICAL RESEARCH, 1984, 32 (05): : A885 - A885
  • [10] Cryptic 5q deletion in a patient with myelodysplastic syndrome
    Medlock, Ruth
    Barrans, Sharon
    Cargo, Catherine
    Kelly, Richard
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (03) : 347 - 347
12345